Andrew J. Schwab, Director, 10% Owner at Skye Bioscience, Inc. (SKYE), sold 33,892 shares at $1.91 ($65K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Open-market sale of $65k SKYE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.91 | 1,285 | $2K | 3.8% |
| 2 | $1.91 | 32,607 | $62K | 96.2% |
| Total | $1.91 avg | 33,892 | $65K | 100% |
| Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |
| SKYE | SELL | 2026-08-20 | $140K | — | Filing → |